News Release

Study finds vision loss due to diabetes is rising globally

Peer-Reviewed Publication

Nova Southeastern University

Janet Leasher, Nova Southeastern University

image: This is Janet Leasher, O.D., M.P.H., co-author of the report and professor at NSU's College of Optometry. view more 

Credit: Nova Southeastern University

FORT LAUDERDALE/DAVIE, Fla. - Diabetes has become one of the top causes of vision loss around the world, according to an article published on August 23, 2016 in Diabetes Care journal by a global consortium led by researchers at Nova Southeastern University's (NSU) College of Optometry in Fort Lauderdale/Davie, Florida, and the Vision and Eye Care Unit at Anglia Ruskin University in Cambridge, United Kingdom.

Blindness and visual impairment due to diabetic retinopathy (DR) increased significantly in the 20-year period researchers analyzed. In 2010, one in every 39 blind people was blind due to DR, which increased 27 percent since 1990. Of those with moderate or severe vision impairment, one in 52 people had vision loss attributed to diabetes, an alarming increase of 64 percent since 1990.

Poor control of glucose levels and lack of access to eye health services in many parts of the world are thought to contribute to this increase, according to the researchers. As more people live longer with diabetes, there is a higher risk of developing DR and subsequent vision loss.

DR is a condition resulting from chronically high blood sugar from diabetes in which the delicate blood vessels in the lining of the inside of the eye (retina) become damaged and start leaking and distorting vision, according to the National Eye Institute. In DR's most advanced stage, new abnormal blood vessels grow, damaging the retina and leading to permanent scarring and vision impairment or blindness.

"Unfortunately diabetic retinopathy usually does not have any symptoms in the early stages," says Janet Leasher, O.D., M.P.H., co-author of the report and a professor at NSU's College of Optometry. "People diagnosed with diabetes should have a dilated eye health exam at least every year and be advised by their eye care practitioner for their personal situation. Patients should work closely with their health care provider to determine the best methods to control their blood sugar levels."

During the 20-year period analyzed in this study, the regions of the world with the highest number of people visually impaired by DR were South Asia, Middle East & North Africa, and West Sub-Saharan Africa. The regions with the highest number of people who were rendered blind from DR were East Asia, Tropical Latin America, and South Sub-Saharan Africa.

In people older than 50, the greatest increase in the prevalence of blindness caused by DR occurred in South Sub-Saharan Africa, Southern Latin America Central Sub-Saharan Africa. Those regions with the greatest increase in the prevalence of visual impairment caused by DR in this age group lived in Central, South and Tropical Latin America. Results showed a slight decrease in visual impairment caused by DR in South and Southeast Asia, Oceania, and East and West Sub-Saharan Africa.

"With the alarming prevalence of vision loss due to diabetes rising more than two-thirds in the last 20 years, the precipitous global epidemic of diabetes must be addressed," said Rupert R.A. Bourne, FRCOphth, M.D., lead investigator of the report, ophthalmologist and professor and associate director of the Vision and Eye Research Unit at Anglia Ruskin University.

The authors recommend public policy planning in regions most affected by DR, including:

  • Strategies for preserving the vision of diabetic adults,

  • Development of evidence-based, cost-effective strategies to screen for DR,

  • Improve control of systemic risk factors (e.g., glucose and blood pressure) among people with diabetes,

  • Increase health education and awareness of the risk of visual loss from DR,

  • Intensified prevention and treatment of DR through the introduction of laser treatments, intra-vitreal injections of steroids and anti-VEGF (vascular endothelial growth factor) drugs, and

  • Reduction of differences between regions in the screening and management of diabetes and DR, socioeconomic factors and medical infrastructure.

The estimates in this study form part of the broader research of the Global Vision Database, which seeks to estimate and report on the changes over time in the causes and prevalence of vision loss.


The research team consisted of Dr. Leasher; Dr. Bourne; Seth R. Flaxman, B.A.; Jost B. Jonas, M.D.; Jill Keeffe, Ph.D.; Kovin Naidoo, O.D., M.P.H.; Konrad Pesudovs, Ph.D.; Holly Price, B.Sc., Ph.D.; Richard A. White, Ph.D.; Tien Y. Wong, M.D., Ph.D.; Serge Resnikoff, M.D., Ph.D.; and Hugh R. Taylor, A.C., M.D., on behalf of the Vision Loss Expert Group of the Global Burden of Disease Study.

Their findings are published in the peer-reviewed journal, Diabetes Care in an article titled "Global Estimates on the Number of People Blind or Visually Impaired by Diabetic Retinopathy: A meta-analysis from 1990-2010." Read the full article at:

This research was partially funded by the Bill & Melinda Gates Foundation, Fight for Sight, Fred Hollows Foundation and the Brien Holden Vision Institute.

About Nova Southeastern University (NSU): Located in beautiful Fort Lauderdale, Florida, Nova Southeastern University (NSU) is a dynamic research institution dedicated to providing high-quality educational programs at the undergraduate, graduate, and first-professional degree levels. A private, not-for-profit institution with more than 26,000 students, NSU has campuses in Fort Lauderdale, Fort Myers, Jacksonville, Miami, Miramar, Orlando, Palm Beach, and Tampa, Florida, as well as San Juan, Puerto Rico, while maintaining a presence online globally. For more than 50 years, NSU has been awarding degrees in a wide range of fields, while fostering groundbreaking research and an impactful commitment to community. Classified as a research university with "high research activity" by the Carnegie Foundation for the Advancement of Teaching, NSU is 1 of only 50 universities nationwide to also be awarded Carnegie's Community Engagement Classification, and is also the largest private, not-for-profit institution in the United States that meets the U.S. Department of Education's criteria as a Hispanic-serving Institution. Please visit for more information about NSU and for more information on the largest fundraising campaign in NSU history.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.